Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.

Cell metabolism | 2019

Glioblastoma multiforme (GBM) undergoes metabolic reprogramming to meet the high ATP and anabolic demands of the tumor cells. However, the role of fatty acid oxidation (FAO) and its regulators in the GBM context has been largely unknown. Here, we show that the neural stem cell pro-proliferative factor acyl-CoA-binding protein (ACBP, also known as DBI) is highly expressed in GBM, and by binding to acyl-CoAs, it cell-autonomously maintains high proliferation rates, promoting tumor growth and poor survival in several preclinical models. Mechanistic experiments using ACBP-acyl-CoA binding affinity variants and pharmacological FAO modulators suggest that ACBP supports tumor growth by controlling the availability of long-chain fatty acyl-CoAs to mitochondria, promoting FAO in GBM. Thus, our findings uncover a critical link between lipid metabolism and GBM progression established by ACBP and offer a potential therapeutic strategy for an effective anti-proliferative metabolic management of GBM.

Pubmed ID: 31056285 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


DBI (diazepam binding inhibitor isoform 2) antibody (antibody)

RRID:AB_2571690

This polyclonal targets mouse DBI, 1-87 aa (NP031856)

View all literature mentions

Anti-GFP antibody (antibody)

RRID:AB_300798

This polyclonal targets GFP

View all literature mentions

BrdU (antibody)

RRID:AB_400326

This monoclonal targets BrdU

View all literature mentions

CPT1A antibody [8F6AE9] (antibody)

RRID:AB_11141632

This monoclonal targets CPT1A antibody [8F6AE9]

View all literature mentions

p21 antibody [EPR3993] (antibody)

RRID:AB_10861551

This monoclonal targets p21 antibody [EPR3993]

View all literature mentions

Ki67 antibody - Proliferation Marker (antibody)

RRID:AB_443209

This polyclonal targets Ki67 antibody - Proliferation Marker

View all literature mentions

ACBP Antibody (antibody)

RRID:AB_2722761

This monoclonal targets ACBP

View all literature mentions

ACBP (FL-87) (antibody)

RRID:AB_2211046

This polyclonal targets DBI

View all literature mentions

OAT1 HEK 293T/17 (cell line)

RRID:CVCL_UE07

Cell line OAT1 HEK 293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCH644 (cell line)

RRID:CVCL_X914

Cell line NCH644 is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

NCH421k (cell line)

RRID:CVCL_X910

Cell line NCH421k is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

U-87MG ATCC (cell line)

RRID:CVCL_0022

Cell line U-87MG ATCC is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

LN-229 (cell line)

RRID:CVCL_0393

Cell line LN-229 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

UMNSAH/DF-1 (cell line)

RRID:CVCL_0570

Cell line UMNSAH/DF-1 is a Spontaneously immortalized cell line with a species of origin Gallus gallus

View all literature mentions